← USPTO Patent Grants

DRG-MDM2-1 for use as a novel Mouse Double Minute 2 (MDM2) inhibitor

Grant US12595232B2 Kind: B2 Apr 07, 2026

Assignee

BAHCESEHIR UNIVERSITESI

Inventors

Timucin Avsar, Serdar Durdagi, Muge Didem Orhan, Maide Nur Paksoy, Gulsah Aydin, Mine Yurtsever

Abstract

The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.

CPC Classifications

C07D 209/18 A61K 45/06 A61K 31/404 A61P 35/02

Filing Date

2021-02-16

Application No.

17904403

Claims

2